<h2 id="introduction">Introduction</h2> <p>The De Novo classification pathway, a crucial facet of the FDA's regulatory framework, is designed to streamline the entry of innovative medical devices that...
<h2 id="introduction">Introduction</h2> <p>The De Novo classification pathway, a crucial facet of the FDA's regulatory framework, is designed to streamline the entry of innovative medical devices that do not have a prior classification. This pathway specifically addresses devices classified as low- to moderate-risk, offering manufacturers a vital route to gain marketing authorization when existing devices cannot serve as predicates. By fostering innovation and enabling the development of groundbreaking technologies, the De Novo classification plays a significant role in enhancing patient care.</p> <p>As the medical device landscape evolves, understanding the intricacies of this process becomes paramount for manufacturers aiming to navigate regulatory challenges effectively. Through a detailed exploration of the De Novo classification’s mechanisms, eligibility criteria, and common pitfalls, insights are provided into how this pathway no…